Sanofi (SNY) Common Equity (2009 - 2026)
Sanofi (SNY) recorded Common Equity of $79.05 billion in Q2 2026, down 4.1% from $82.42 billion a year earlier.
Analysis
Sanofi (SNY) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Sanofi reported Common Equity of $83.85 billion, up 3.5% from FY2024.
- Annual Common Equity has a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $81.02 billion in FY2024 (-1.1%), $81.95 billion in FY2023 (+2.8%), $79.73 billion in FY2022 (+2.5%) and $77.78 billion in FY2021 (+0.2%).
- The Q2 2026 figure is the lowest quarterly Common Equity since Q2 2024.
- On a year-over-year basis, Common Equity rose in two of the last four quarters, with growth averaging 1.0%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 6.5% in Q2 2023, against a decline of 4.1% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,289.41 Bn | 1,263.02 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 687.33 Bn | 607.19 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 524.88 Bn | 492.89 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 361.94 Bn | 324.89 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 313.59 Bn | 286.83 Bn | - | - |
| 6 | Astrazeneca | 287.15 Bn | 260.67 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 253.53 Bn | 205.18 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 210.46 Bn | 185.57 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.39 Bn | 112.74 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Sanofi | 59.45 Bn | 29.65 Bn | 33.35 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.05 Bn |
| Dec 31, 2025 | 83.85 Bn |
| Jun 30, 2025 | 82.42 Bn |
| Dec 31, 2024 | 81.02 Bn |
| Jun 30, 2024 | 77.84 Bn |
| Dec 31, 2023 | 81.95 Bn |
| Jun 30, 2023 | 78.93 Bn |
| Dec 31, 2022 | 79.73 Bn |
| Jun 30, 2022 | 74.12 Bn |
| Dec 31, 2021 | 77.78 Bn |
| Jun 30, 2021 | 75.26 Bn |
| Dec 31, 2020 | 77.62 Bn |
| Jun 30, 2020 | 71.20 Bn |
| Dec 31, 2019 | 66.35 Bn |
| Jun 30, 2019 | 64.28 Bn |
| Dec 31, 2018 | 67.54 Bn |
| Mar 31, 2018 | 71.67 Bn |
| Dec 31, 2017 | 69.55 Bn |
| Jun 30, 2017 | 66.12 Bn |
| Dec 31, 2016 | 61.04 Bn |
API Access
Sanofi Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=SNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();